Read + Share
Laragione T, Harris C, Gulko PS. Combination therapy of a TRPV2 agonist with a TNF inhibitor achieves sustained
suppression of disease severity and reduced joint damage. Clin Exp Immunol 2023;211:233-238.
PMID: 36571199
|
 |
|
Laragione T, Harris C, Gulko PS. Combination therapy of a TRPV2 agonist with a TNF inhibitor achieves sustained
suppression of disease severity and reduced joint damage. Clin Exp Immunol 2023;211:233-238.
PMID: 36571199
|
|
|
|